Ajanta Pharma Ltd

Common Name
Ajanta Pharma
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,628
Ticker
AJANTPHARM
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Ajanta Pharma Ltd. is a leading pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of branded and generic pharmaceuticals. Established in 1973, the company h...

Financial Statements of Ajanta Pharma

Below are the financial statements of Ajanta Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in billions of INR20252024
Income
Revenue from operations
46.48a
42.09a
Other income
0.95a
0.85a
Total income
47.43a
42.93a
Expenses
Cost of materials consumed
-8.47a
-9.39a
Purchase of stock-in-trade
-2.5a
-1.66a
Changes in inventories of finished goods/stock-in-trade/work-in-progress
-0.26a
-0.39a
Employee benefits expense
-10.9a
-9a
Finance costs
-0.21a
-0.07a
Depreciation and amortisation expense
-1.44a
-1.35a
Other expenses
-12.28a
-10.7a
Total expenses
-35.53a
-31.79a
Profit before tax
11.89a
11.14a
Current tax
For current year
-3.37a
-2.98a
For earlier years
-0.25a
-0.24a
Tax expense
Deferred tax
-0.44a
-0.24a
Total tax expense
-2.69a
-2.98a
Profit for the year
9.2a
8.16a

Verified Sources Behind Ajanta Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ajanta Pharma’s data sources below and access millions more through our Disclosure Search.

a. Ajanta Pharma's Annual Report 2025
Trace every data point back to Ajanta Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?